Hildinger M - Search Results

1

Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells.

Knipper R, Kuehlcke K, Schiedlmeier B, Hildinger M, Lindemann C, Schilz AJ, Fauser AA, Fruehauf S, Zeller WJ, Ostertag W, Eckert HG, Baum C. Knipper R, et al. Among authors: hildinger m. Gene Ther. 2001 Feb;8(3):239-46. doi: 10.1038/sj.gt.3301384. Gene Ther. 2001. PMID: 11313796

2

Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors.

Hildinger M, Fehse B, Hegewisch-Becker S, John J, Rafferty JR, Ostertag W, Baum C. Hildinger M, et al. Hum Gene Ther. 1998 Jan 1;9(1):33-42. doi: 10.1089/hum.1998.9.1-33. Hum Gene Ther. 1998. PMID: 9458240

3

FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells.

Hildinger M, Eckert HG, Schilz AJ, John J, Ostertag W, Baum C. Hildinger M, et al. Gene Ther. 1998 Nov;5(11):1575-9. doi: 10.1038/sj.gt.3300759. Gene Ther. 1998. PMID: 9930313

4

Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.

Hildinger M, Schilz A, Eckert HG, Bohn W, Fehse B, Zander A, Ostertag W, Baum C. Hildinger M, et al. Gene Ther. 1999 Jul;6(7):1222-30. doi: 10.1038/sj.gt.3300942. Gene Ther. 1999. PMID: 10455430

5

Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.

Baum C, Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Hildinger M, Uhde A, John J, Ostertag W. Baum C, et al. Among authors: hildinger m. J Hematother. 1996 Aug;5(4):323-9. doi: 10.1089/scd.1.1996.5.323. J Hematother. 1996. PMID: 8877707 Review.

6

A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents.

Jelinek J, Rafferty JA, Cmejla R, Hildinger M, Chinnasamy D, Lashford LS, Ostertag W, Margison GP, Dexter TM, Fairbairn LJ, Baum C. Jelinek J, et al. Among authors: hildinger m. Gene Ther. 1999 Aug;6(8):1489-93. doi: 10.1038/sj.gt.3300962. Gene Ther. 1999. PMID: 10467374

7

Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors.

Schambach A, Wodrich H, Hildinger M, Bohne J, Kräusslich HG, Baum C. Schambach A, et al. Among authors: hildinger m. Mol Ther. 2000 Nov;2(5):435-45. doi: 10.1006/mthe.2000.0191. Mol Ther. 2000. PMID: 11082317 Free article.

8

Lack of superinfection interference in retroviral vector producer cells.

Vogt B, Roscher S, Abel B, Hildinger M, Lamarre A, Baum C, von Laer D. Vogt B, et al. Among authors: hildinger m. Hum Gene Ther. 2001 Mar 1;12(4):359-65. doi: 10.1089/10430340150503984. Hum Gene Ther. 2001. PMID: 11242528

9

Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents.

Rappa G, Lorico A, Hildinger M, Fodstad Ø, Baum C. Rappa G, et al. Among authors: hildinger m. Hum Gene Ther. 2001 Sep 20;12(14):1785-96. doi: 10.1089/104303401750476276. Hum Gene Ther. 2001. PMID: 11560771

10

Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer.

Cmejlova J, Hildinger M, Cmejla R, Fuchs O, Kalabova D, Baum C, Jelinek J. Cmejlova J, et al. Among authors: hildinger m. Gene Ther. 2003 Jun;10(12):1061-5. doi: 10.1038/sj.gt.3301967. Gene Ther. 2003. PMID: 12776165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters